MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

12 Aug 2024 Evaluate
The sales declined to Rs. 247.80 millions for the June 2024 quarter as compared to Rs. 268.35 millions during the corresponding quarter last year.Profit after tax improved marginally to Rs. 46.52  millions for the quarter ended June 2024 from Rs. 45.40 millions of corresponding previous quarter.Operating profit surged to 86.69 millions from the corresponding previous quarter of 72.32 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 247.80 268.35 -7.66 247.80 268.35 -7.66 1258.95 913.58 37.80
Other Income 5.45 3.20 70.31 5.45 3.20 70.31 30.67 7.17 327.75
PBIDT 86.69 72.32 19.87 86.69 72.32 19.87 448.77 241.60 85.75
Interest 3.16 0.34 829.41 3.16 0.34 829.41 5.98 1.80 232.22
PBDT 83.53 71.98 16.05 83.53 71.98 16.05 442.79 239.80 84.65
Depreciation 20.18 10.11 99.60 20.18 10.11 99.60 61.10 37.42 63.28
PBT 63.35 61.87 2.39 63.35 61.87 2.39 381.69 202.38 88.60
TAX 16.83 16.47 2.19 16.83 16.47 2.19 100.52 50.53 98.93
Deferred Tax 0.28 0.19 47.37 0.28 0.19 47.37 6.74 -2.84 -337.32
PAT 46.52 45.40 2.47 46.52 45.40 2.47 281.17 151.85 85.16
Equity 128.38 125.69 2.14 128.38 125.69 2.14 125.83 121.07 3.93
PBIDTM(%) 34.98 26.95 29.81 34.98 26.95 29.81 35.65 26.45 34.79
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..